BEng BSc - Medibank Private Group Strategy
| MPV Stock | EUR 2.28 0.02 0.88% |
Insider
BEng BSc is Group Strategy of Medibank Private Limited
| Phone | 61 3 8622 5222 |
| Web | https://www.medibank.com.au |
Medibank Private Management Efficiency
The company has return on total asset (ROA) of 0.0906 % which means that it generated a profit of $0.0906 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.208 %, meaning that it generated $0.208 on every $100 dollars invested by stockholders. Medibank Private's management efficiency ratios could be used to measure how well Medibank Private manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Tomas Duffy | SIVERS SEMICONDUCTORS AB | 62 | |
| Bjorn Norrbom | SIVERS SEMICONDUCTORS AB | 72 | |
| Erik Wiklund | SIVERS SEMICONDUCTORS AB | 49 | |
| Manfred Mueller | Identiv | 53 | |
| Yasheng Yang | Origin Agritech | 51 | |
| CCLP CMA | Superior Plus Corp | 62 | |
| Gregory Abel | Berkshire Hathaway | 61 | |
| Ingrid Engstrom | SIVERS SEMICONDUCTORS AB | 59 | |
| Patric Erlandsson | SIVERS SEMICONDUCTORS AB | 51 | |
| Jan Wicke | Talanx AG | 55 | |
| Larry Cordell | Origin Agritech | 56 | |
| Allison Miller | NMI Holdings | N/A | |
| Caroline Schlienkamp | Talanx AG | 49 | |
| Mike Taylor | Identiv | N/A | |
| Edgar Puls | Talanx AG | 50 | |
| FCA FCA | Superior Plus Corp | 68 | |
| Gengchen Han | Origin Agritech | 58 | |
| James Devens | Superior Plus Corp | N/A | |
| Peter Eastwood | Berkshire Hathaway | N/A | |
| Michael Pille | Berkshire Hathaway | N/A | |
| Wilm Langenbach | Talanx AG | 52 | |
Management Performance
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0906 |
Medibank Private Leadership Team
Elected by the shareholders, the Medibank Private's board of directors comprises two types of representatives: Medibank Private inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medibank. The board's role is to monitor Medibank Private's management team and ensure that shareholders' interests are well served. Medibank Private's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medibank Private's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BA BA, Governance Legal | ||
| Peter Kopanidis, Sr Fin | ||
| BSc BSc, Group Operations | ||
| Emily Ritchie, Sr Affairs | ||
| BEng BSc, Group Strategy | ||
| BCom BCom, MD CEO | ||
| Milosh Milisavljevic, Group Portfolios | ||
| Colette Campbell, Sr Relations | ||
| FACHSE FRANZCP, Group Health |
Medibank Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medibank Private a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0906 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 4.91 B | |||
| Shares Outstanding | 2.75 B | |||
| Shares Owned By Insiders | 0.63 % | |||
| Shares Owned By Institutions | 36.93 % | |||
| Price To Earning | 18.36 X | |||
| Price To Book | 4.14 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Medibank Stock
Medibank Private financial ratios help investors to determine whether Medibank Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medibank with respect to the benefits of owning Medibank Private security.